Dianthus Therapeutics Inc...

NASDAQ: DNTH · Real-Time Price · USD
18.83
0.26 (1.40%)
At close: Jun 06, 2025, 3:59 PM
18.85
0.11%
After-hours: Jun 06, 2025, 04:20 PM EDT

Dianthus Therapeutics Revenue Breakdown

Period Ending Dec 31, 2024
License Revenue 326K
License Revenue Growth n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Selling, General, and Administrative Revenue 7.34M 6.83M 6.53M 5.89M 5.64M 4.53M 8.72M 5.32M 6.13M 2.04M 2.21M 6.48M 7.29M 7.03M 7.45M 6.48M 6.97M 6.81M 6.59M 7.4M 7.28M 5.92M 6.12M 5.91M 5.81M 5.54M 5.28M 4.34M 3.46M 2.62M 1.8M 1.92M 1.49M
Selling, General, and Administrative Revenue Growth +7.44% +4.61% +10.91% +4.36% +24.53% -48.08% +64.03% -13.27% +201.03% -7.79% -65.91% -11.07% +3.71% -5.69% +14.95% -7.00% +2.35% +3.24% -10.90% +1.66% +22.93% -3.22% +3.64% +1.58% +4.93% +4.84% +21.70% +25.60% +32.00% +45.10% -5.74% +28.61% n/a
Research and Development Revenue 27M 26.41M 25.54M 18.07M 13.08M 8.78M 7.96M 139K 6.79M 9.83M 7.22M 10.41M 16.55M 13.11M 10.79M 11.13M 11.73M 12.26M 11.79M 12.61M 13.96M 18.71M 16.52M 13.43M 10.54M 12.39M 11.42M 9.68M 7.85M 5.55M 5.21M 13.82M 3.32M
Research and Development Revenue Growth +2.23% +3.40% +41.36% +38.17% +48.94% +10.31% +5626.62% -97.95% -30.95% +36.20% -30.64% -37.11% +26.18% +21.48% -3.00% -5.11% -4.31% +3.99% -6.53% -9.69% -25.39% +13.25% +23.01% +27.48% -14.96% +8.51% +17.92% +23.37% +41.40% +6.55% -62.29% +315.89% n/a